Sphingosine-1-phosphate receptor agonist iontophoretic devices and methods of using the same
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Jun 9, 2020
Grant Date -
Apr 16, 2015
app pub date -
Aug 29, 2014
filing date -
Oct 11, 2013
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
Iontophoretic devices for transdermal delivery of a sphingosine-1-phosphate receptor agonist active agent are provided. Also provided are methods of transdermally delivering a therapeutically effective amount of a sphingosine-1-phosphate receptor agonist active agent to a subject, e.g., to treat immune system disorders such as multiple sclerosis. Packaged iontophoretic systems, kits including iontophoretic devices, and methods of making iontophoretic devices are also provided.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully